Cleared Traditional

HERPES SIMPLEX VIRUS TYPE 1 IGG ELISA TEST (K131334) - FDA 510(k) Clearance

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K131334 · Gold Standard Diagnostics · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
295d
Days
Class 2
Risk

K131334 is an FDA 510(k) clearance for the HERPES SIMPLEX VIRUS TYPE 1 IGG ELISA TEST. Classified as Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1 (product code MXJ), Class II - Special Controls.

Submitted by Gold Standard Diagnostics (Davis, US). The FDA issued a Cleared decision on February 28, 2014 after a review of 295 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Gold Standard Diagnostics devices

Submission Details

510(k) Number K131334 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2013
Decision Date February 28, 2014
Days to Decision 295 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
193d slower than avg
Panel avg: 102d · This submission: 295d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MXJ Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - MXJ Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1

Devices cleared under the same product code (MXJ) and FDA review panel - the closest regulatory comparables to K131334.
ARCHITECT HSV-1 IgG, ARCHITECT HSV-1 IgG Calibrator, ARCHITECT HSV-1 IgG Controls
K213987 · Biokit, S.A. · Sep 2023
Elecsys HSV-1 IgG (08948844160)
K220923 · Roche Diagnostics · Oct 2022
ADVIA Centaur Herpes-1 IgG
K181333 · Biokit, S.A. · Aug 2018
ELECSYS HSV-1 IGG IMMUNOASSAY ELECSYS PRECICONTROL HSV
K120625 · Roche Diagnostics · Jul 2012
ZEUS ELISA HSV GC-I IGG TEST SYSTEM
K103363 · Zeus Scientific, Inc. · Apr 2011
ATHENA MULTI-LYTE HSV 1 & 2 IGG TEST SYSTEM
K072178 · Zeus Scientific, Inc. · May 2008